UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST
- Country
- ๐ฌ๐งUnited Kingdom
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.uhs.nhs.uk
Prebiotics and Immune Function in Middle Aged Humans
- Conditions
- Immune Function
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Prebiotic
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2014-12-02
- Target Recruit Count
- 49
- Registration Number
- NCT00898599
- Locations
- ๐ฌ๐ง
University of Southampton, Southampton, United Kingdom
Salmon in Pregnancy Study
- Conditions
- AllergiesDermatitisAsthma
- Interventions
- Other: ControlDietary Supplement: Oily fish consumption
- First Posted Date
- 2008-12-03
- Last Posted Date
- 2014-12-02
- Target Recruit Count
- 124
- Registration Number
- NCT00801502
- Locations
- ๐ฌ๐ง
University of Southampton, Southampton, United Kingdom
Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acids
- Conditions
- Non-Alcoholic Fatty Liver Disease
- Interventions
- Drug: Placebo oral capsuleDrug: OMACOR
- First Posted Date
- 2008-09-26
- Last Posted Date
- 2019-10-25
- Target Recruit Count
- 103
- Registration Number
- NCT00760513
- Locations
- ๐ฌ๐ง
Southamption General Hospital, Southampton, Hants, United Kingdom
Evaluation of Corticosteroid Therapy in Childhood Severe Sepsis - a Randomised Pilot Study
- First Posted Date
- 2008-08-11
- Last Posted Date
- 2016-05-06
- Target Recruit Count
- 21
- Registration Number
- NCT00732277
- Locations
- ๐ฌ๐ง
Bristol Royal Hospital for Children, Bristol, UK, United Kingdom
๐ฌ๐งImperial College Healthcare NHS Trust, London, UK, United Kingdom
๐ฌ๐งSouthampton University Hospitals NHS Trust, Southampton, UK, United Kingdom
Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma
- Conditions
- Lymphoma
- Interventions
- Biological: rituximabBiological: filgrastimBiological: bleomycin sulfate
- First Posted Date
- 2008-06-04
- Last Posted Date
- 2009-07-08
- Target Recruit Count
- 120
- Registration Number
- NCT00689845
- Locations
- ๐ฌ๐ง
Leeds Cancer Centre at St. James's University Hospital, Leeds, England, United Kingdom
๐ฌ๐งChristie Hospital, Manchester, England, United Kingdom
๐ฌ๐งSouthampton General Hospital, Southampton, England, United Kingdom
Implications for Treatment of the Metabolic Syndrome
- First Posted Date
- 2008-04-24
- Last Posted Date
- 2019-01-23
- Target Recruit Count
- 40
- Registration Number
- NCT00666029
Follow-Up Study of Patients Who Have Undergone Surgery for Stage I, Stage II, or Stage III Colorectal Cancer
- Conditions
- Colorectal Cancer
- First Posted Date
- 2007-11-19
- Last Posted Date
- 2011-08-08
- Target Recruit Count
- 4760
- Registration Number
- NCT00560365
- Locations
- ๐ฌ๐ง
Grantham and District Hospital, Grantham, Lincolnshire, England, United Kingdom
๐ฌ๐งLeeds General Infirmary, Leeds, England, United Kingdom
๐ฌ๐งQueen's Hospital, Burton-upon-Trent, England, United Kingdom
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer
- Conditions
- Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2013-08-26
- Target Recruit Count
- 360
- Registration Number
- NCT00363584
- Locations
- ๐ฌ๐ง
Huddersfield Royal Infirmary, Huddersfield, West Yorks, England, United Kingdom
๐ฌ๐งSt. Thomas' Hospital, London, England, United Kingdom
๐ฌ๐งRoyal Bournemouth Hospital, Bournemouth, England, United Kingdom